Home › Funds › Marshall Wace › CMPX
Marshall Wace position in CMPX
COMPASS THERAPEUTICS INC · Health Care
Latest position (Q2 2026)334.87K sh
Reported value held$733.36K
Portfolio Weight0.00%
First reportedQ2 2022
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 23.73K | $63.00K | New |
| Q3 2022 | 51.82K | $117.00K | Add |
| Q4 2022 | 28.30K | $142.33K | Reduce |
| Q1 2023 | 65.18K | $213.13K | Add |
| Q4 2025 | 1.26M | $6.79M | New |
| Q2 2026 | 334.87K | $733.36K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CMPX
- Vanguard Group 8.05M sh · $43.22M · Q4 2025
- BlackRock Inc 11.28M sh · $24.71M · Q2 2026
- Millennium Management 4.71M sh · $10.32M · Q2 2026
- Geode Capital Management 3.82M sh · $8.36M · Q2 2026
- Citadel Advisors 3.71M sh · $8.12M · Q2 2026
- Goldman Sachs Group 3.53M sh · $7.73M · Q2 2026
- AQR Capital Management 3.51M sh · $7.69M · Q2 2026
- Royce & Associates 1.34M sh · $2.93M · Q2 2026
- Fidelity Management & Research (FMR) 1.21M sh · $2.65M · Q2 2026
- Northern Trust Corp 1.14M sh · $2.50M · Q2 2026
- JPMorgan Chase & Co 789.40K sh · $1.71M · Q2 2026
- Morgan Stanley 735.19K sh · $1.61M · Q2 2026